- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02935062
New Therapeutical Perspectives in Cases of Phonological Disorders
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio Grande Do Sul
-
Santa Maria, Rio Grande Do Sul, Brazil, 97015-372
- Universidade Federal de Santa Maria- campus Camobi e centro- Floriano Peixoto 1709.
-
Santa Maria, Rio Grande Do Sul, Brazil, 97060-500
- Federal University of Santa Maria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents/guardians and child agree to participate and have signed the Informed Consent Form;
- Have age between 4:0 to 8:11 (years:months);
- Present diagnosis of phonological disorders;
- Present hearing thresholds within the normal range
Exclusion Criteria:
- Present neurological impairment, emotional and/or cognitive clearly diagnosed, or have complaint;
- Present any degree of hearing loss is the type conductive, mixed or sensorineural, and middle ear disorders in time of selection, as well as having presented otitis complaints;
- Present language impairment associated with speech sound disorder;
- Present commitment in the stomatognathic system that can interfere in the speech production;
- Have been received speech and language therapy before.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional Phonological Therapy
This intervention will be intermediated by the traditional model cycles.
This approach has the principle of treating the suppression of operant phonological processes in child's speech, from the awareness of sound-target characteristics operating in that phonological process.
|
Phonological therapy based on generalizing the sounds presented by figures, repetition and naming words.
|
|
Experimental: Software Phonological Therapy- SIFALA
This intervention will be intermediated by the software SIFALA.
The software SIFALA, allows to select target segments using the Modelo de Estratos (second model Strata), based on the level segment of production and complexity of distinctive features, from the child's sound system analysis and planned generalizations.
It also seeks the treatment of phonological disorders, by selection stimulus words in more favorable environments and playful activities with computer resource for the correct production of the target segment in the words stimulus, promoting the spread segments.
|
The phonological thearapy of this group will be based on software use with phonological model already developed, using naming and repetition of sounds.
|
|
Placebo Comparator: Placebo Therapy
No interventional group.
This group will be the sham group.
The proposed activities will be fun games on the computer, there is no relationship with speech and it will be not emphasized the correct sound production, will only play activities.
|
No intervention to improve speech.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument
Time Frame: 10 weeks
|
The percentage of correct consonants corresponds to the number of phonemes produced by the child, evaluated initially before starting treatment and at the end of treatment.
The variable of this calculation is based on the percentage which is determined at what phonological level of disorder the child is at.
It is expected that at the end of treatment the percentage of correct consonants will increase due to the therapy stimuli offered.
|
10 weeks
|
|
P300- Long-latency Auditory Evoked Potential
Time Frame: 10 weeks.
|
Electrophysiological evaluation of the auditory pathway through the protocol, Pretreatment and Post-treatment P300 waves were analyzed by the latency according to the parameters of MacPherson (1996). The electrophysiological protocol was performed before and after therapy. The marking of the waves was judged by specialist judges in the field of audiology. The variable that predicts P300 latency is quantified in milliseconds (ms |
10 weeks.
|
Collaborators and Investigators
Investigators
- Study Director: Marcia Keske-Soares, PhD, Universidade Federal de Santa Maria
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 28053914.1.0000.5346
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The plan to make the individual data available is in accordance with the criteria adopted in the research and the research ethics committee of the educational institution, which developed the study.
The results, placed on the platform of this randomized clinical trial, can be used by other researchers.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ICF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.